SBIR Phase I: Novel Advanced Nematicides with Improved Efficacy and Safety

Information

  • NSF Award
  • 0944853
Owner
  • Award Id
    0944853
  • Award Effective Date
    1/1/2010 - 14 years ago
  • Award Expiration Date
    6/30/2010 - 14 years ago
  • Award Amount
    $ 150,000.00
  • Award Instrument
    Standard Grant

SBIR Phase I: Novel Advanced Nematicides with Improved Efficacy and Safety

This SBIR Phase I project will develop novel nematicides using proprietary chemical design and screening methods. The project will first design, prioritize, and synthesize a set of entirely novel molecules. The project will then evaluate compounds for activity in multiple biological assays with parasitic nematodes and plants. Promising scaffolds will be prioritized for further development in Phase II including assessment of toxicity, manufacturing cost, and additional synthetic opportunities.<br/><br/>The broader/commercial impact of the project will be to protect crops against nematodes which result in significant benefit to growers and the environment. The potential value to Divergence is very large, with the current nematicide market of $1 billion under representing the actual value that could be generated. REsulting effective nematicides with superior safety to current prodicts will be of immediate benefit to growers, consumers, and the environment.

  • Program Officer
    Anthony Walters
  • Min Amd Letter Date
    11/13/2009 - 14 years ago
  • Max Amd Letter Date
    11/13/2009 - 14 years ago
  • ARRA Amount

Institutions

  • Name
    Divergence, Inc.
  • City
    Saint Louis
  • State
    MO
  • Country
    United States
  • Address
    1005 North Warson Road
  • Postal Code
    631322900
  • Phone Number
    3148128024

Investigators

  • First Name
    Urszula
  • Last Name
    Slomczynska
  • Email Address
    slomczynska@divergence.com
  • Start Date
    11/13/2009 12:00:00 AM

FOA Information

  • Name
    Industrial Technology
  • Code
    308000